Gufic Biosciences Ltd.
Lyophilized and injectable pharmaceuticals
Gufic Biosciences manufactures lyophilized injections, specialty injectables, and botanical extracts. Its GMP-certified facilities in Gujarat and Karnataka produce novel drug delivery systems and high-value generics. The company is a market leader in India for several niche injectable products and has a growing international footprint.
- Type
- Manufacturer
- Location
- Mumbai, India
- Founded
- 1970
- Website
- https://www.gufic.com
- Categories
- Medical & Healthcare Supplies
- Markets
- United States, United Kingdom, United Arab Emirates, Saudi Arabia
Verified facts
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- product-authorised-for-sale (green), checked 2026-08-20 NAFDAC Greenbook, Nigeria - register of authorised products (manufacturer named on the authorisation)
- cin-on-site (amber), checked 2026-08-11 Published on the company's own website
- domain-registered (green), checked 2026-08-08 Domain registry record
- export-registered (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- registered-manufacturer (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- lei-active (green), checked 2026-08-23 GLEIF global LEI register (golden copy)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)